SAC StudioThe 400 mg dose and the COA behind it were never panel-verified — and the ASIN is now delisted.
Toniiq Ultra High Strength L-Theanine's headline claims — 400 mg per capsule, a third-party COA confirming 98%+ L-isomer purity, the lowest ¢-per-active-mg on the listicle — built a 9.0 'buy' score in an earlier version of this review. We could not verify any of them. No gallery photo for this ASIN (B07XL9F46H) ever showed a legible Supplement Facts panel, and as of Sep 8, 2026 Toniiq's Amazon listing for this product is delisted: we checked searchItems and the brand's own page and found no live listing to check a single figure against.
So the 400 mg dose, the 98%+ purity COA, the GMP-certified-facility claim, and the $0.05-per-100mg math built on top of both are now attributed to this review's own prior text. We could not verify any of it against a label, because none was ever legible. What survives: the underlying research on L-theanine's focus and stress-reduction mechanism (Owen 2008, Nobre 2008, Higashiyama 2011, Hidese 2019), which doesn't depend on this specific bottle's panel.
What doesn't survive: the confidence this review used to sell. Corrected score: 3.3, 'skip' — not because 400 mg would be a bad dose if confirmed, but because nothing about this product's content, purity, or even its current availability can be checked.
400 mg per capsule was this review's own prior claim; we could not confirm it against a legible panel then, and we can't now — Toniiq's Amazon listing for this ASIN is delisted as of Sep 8, 2026, so there is no gallery left to check it against. Taken at face value, 400 mg would sit at the top of the validated 100-400 mg window characterized by Higashiyama 2011 and twice the Owen 2008 acute-focus dose. But 'taken at face value' is now the entire basis for the number — a competitor whose dose a legible panel actually confirms scores higher here by definition. We can't rule the figure in or out; we can only say it is not verifiable.
Generic L-Theanine (not Suntheanine-patented) carries a real risk: some generic suppliers ship racemic L+D mixtures where 30-50% of the labeled mg is the inactive D-isomer. A published, checkable third-party COA is the one thing that closes that gap — and we could never check one. No gallery photo for this ASIN ever showed a legible Supplement Facts panel, and the listing is now delisted, so the '98%+ L-isomer purity' figure this review used to credit is an unconfirmed brand claim, not a panel- or COA-verified fact. Scored as generic-with-unconfirmed-purity, which is a materially worse position than generic-with-a-checkable-COA.
Corrected down from 8.3. That score credited 'published per-batch third-party COAs' and a GMP-certified facility as established transparency — but no gallery photo for this ASIN ever showed a legible Supplement Facts panel, and Toniiq's listing is now delisted, so there is nothing left to check a COA link or a GMP claim against. The credential that used to separate this product from the rest of the category — checkable proof of what's in the cap — turned out to be unconfirmed. What remains is a set of brand statements we could not check.
The $0.05-per-100mg figure needs two inputs we can no longer verify: a confirmed 400 mg dose (unconfirmed — see the Dose criterion) and a current price (unconfirmed — the ASIN is delisted, so there is no live buy box to read a price from). The $24/month figure carried below is preserved as this review's last-known listing price, not a current, checkable value case. A reader cannot actually realize this cost-per-mg today, because the product is not purchasable.
The 120-capsule count and vegetable-cellulose capsule shell are plausible, low-stakes claims, but they rest on the same now-unconfirmed listing as everything else here, and the more basic problem is availability: a delisted ASIN is not a format you can actually buy today. What would otherwise be a genuine strength — one cap covering the trial-upper-range dose, splittable for the acute-focus protocol — is moot until the dose itself is confirmed and the product is purchasable again.
“400 mg per capsule — ultra high strength.”
An earlier version of this review counted this as verified via Toniiq's third-party COA. We could not verify it now: no gallery photo for this ASIN ever showed a legible Supplement Facts panel, and Toniiq's listing is delisted as of Sep 8, 2026, so there is nothing left to check the figure against. Treat 400 mg as this review's own prior, unconfirmed claim.
“98%+ purity, third-party tested.”
An earlier version of this review counted this as verified via Toniiq's published COA. We could not verify it: no gallery photo ever showed a legible Supplement Facts panel, and the ASIN is now delisted, so there's no listing left to check a COA claim against. Treat 98%+ purity as an unconfirmed brand claim.
“Supports focus and stress relief.”
Verified by Owen 2008 (focus + caffeine stack), Nobre 2008 (alpha-wave EEG), and Higashiyama 2011 (stress response reduction at 200-400 mg). The dual focus + stress claim is one of the better-supported in the natural-nootropic category, and this evidence is about L-theanine generally, not about this specific bottle's unconfirmed dose.
“Non-GMO, vegan, gluten-free.”
An earlier version of this review called these 'on-label and verifiable.' The listing claims all three, and the vegetable-cellulose (non-gelatin) capsule shell is consistent with that — but no gallery photo shows a legible Supplement Facts panel or Other-Ingredients line to check it against, and the ASIN is now delisted. Treat this as the listing's claim, not a panel-verified fact.
“Promotes restful sleep.”
True for sleep onset in the research literature — the alpha-wave + GABA modulation smooths pre-sleep mental chatter at 200-400 mg taken 30-60 minutes before bed, supported by Hidese 2019. The 'restful sleep' framing overstates if read as 'L-Theanine is a sedative' — it isn't, and it doesn't enforce sleep maintenance. Directionally true for sleep onset generally. How much of that effect this specific, now-delisted bottle would deliver is unconfirmed. The listing's claimed 400 mg dose was never checked against a legible panel — none ever surfaced for this ASIN, so we could not confirm it.
An earlier version of this review stated the 400 mg per-capsule dose and the 98%+ L-isomer purity COA as verified, panel-confirmed facts — the product's entire 'buy' case (badge, lead, every criterion, and four of five claims marked 'verified') was built on that footing. We re-checked src/data/label-facts/B07XL9F46H.json on Sep 8, 2026: readable:false. Toniiq's Amazon listing for this ASIN is delisted — we checked searchItems and the brand's own page and found no live listing for the same product — so there is no gallery left to check for a legible Supplement Facts panel, and no way to reconfirm any figure this review used to state as fact. There is no panel we can see, and no live listing to check the brand's own third-party-COA claim against. What we could not confirm: the 400 mg per-capsule dose, the 98%+ L-isomer purity figure, the third-party COA itself, the GMP-certified-facility claim, the Non-GMO/vegan/gluten-free certifications, the inactive-ingredient list, and the $24/month price. We've rewritten every one of those as an unconfirmed legacy claim from this review's own prior text, not a label fact, and corrected the criteria that were scored on the strength of a panel or COA we never actually saw.
The 'ultra high strength' framing in Toniiq's marketing implies dosing at or near the top of the safe trial window. The research says: Owen 2008 used 100-200 mg paired with caffeine, Higashiyama 2011 used 200 mg and characterized a ceiling effect at 200-400 mg (additional dose doesn't add additional stress-reduction signal), and Hidese 2019 used 200 mg for sleep onset. If Toniiq's claimed 400 mg per cap is accurate, it would sit at the high end of validated dosing without pushing past the well-tolerated window. But 'if' is the operative word: no gallery photo for this ASIN ever showed a legible Supplement Facts panel, and the listing is now delisted, so we could not confirm the 400 mg figure the way we could for a competitor's still-live, panel-legible listing.
An earlier version of this review calculated Toniiq at $24/month for 120 × 400 mg = 48 g of L-Theanine per month = $0.05 per 100 mg, against NOW Foods (#1) at roughly $0.09 per 100 mg and Sports Research (#2) at roughly $0.17 per 100 mg — making Toniiq the cheapest per active mg on the listicle by a wide margin. Every input in that calculation is now unconfirmed: the 400 mg dose was never checked against a legible panel, and the $24/month price has no live listing behind it, since the ASIN is delisted as of Sep 8, 2026. We're leaving the historical arithmetic here for the record, not as a reason to buy — a reader cannot currently obtain this product at any price.
If you're buying L-Theanine for pure acute focus + caffeine stacking, NOW Foods at 200 mg per cap (Suntheanine, its own listing) is the safer format — the Owen 2008 trial-replication dose. Toniiq's listing claimed a 400 mg cap for the stress/sleep crossover — morning focus plus evening sleep onset, or all-day stress reduction at 200-400 mg total daily — which the Higashiyama 2011 ceiling effect would support if that dose figure held. It no longer matters which protocol suits you better: the ASIN is delisted, so this specific product isn't a live option either way.
Generic L-Theanine carries a real risk: some suppliers ship racemic mixtures (L+D Theanine) where 30-50% of the labeled mg is the inactive D-isomer. Suntheanine's patent guarantees enantiomerically pure L-isomer; a published, checkable third-party COA is the only other way to close that gap for a generic product. Toniiq's listing claimed exactly that — a COA confirming 98%+ L-isomer purity — but no gallery photo for this ASIN ever showed a legible Supplement Facts panel, and the listing is now delisted, so there was never a way to check that COA claim, and there no longer is one at all. An earlier version of this review told readers to 'verify the COA before buying'; we tried, and could not, which is the whole finding.
L-Theanine's alpha-wave + GABA mechanism is orthogonal to caffeine (adenosine antagonism), Alpha-GPC (acetylcholine substrate), and Lion's Mane (NGF + myelin) — that stacking logic doesn't depend on this specific bottle's unconfirmed dose. If you're building a four-mechanism knowledge-worker stack, the L-Theanine component should come from a pick whose dose you can actually verify; Toniiq's claimed 200-400 mg is not currently checkable, and the product itself is delisted.
An earlier version of this review scored Toniiq 9.0 as the 'best ¢-per-mg L-Theanine,' built entirely on a 400 mg per-capsule dose and a third-party COA confirming 98%+ L-isomer purity — both stated as confirmed fact. We re-checked src/data/label-facts/B07XL9F46H.json on Sep 8, 2026: no gallery photo for this ASIN ever showed a legible Supplement Facts panel, and Toniiq's Amazon listing for this product is delisted, with no live listing left to check a single figure against. Every number this review used to publish as fact — the dose, the purity, the price, the certifications — is now an unconfirmed legacy claim, not a label we verified. The research behind L-theanine itself is not in question: Owen 2008, Nobre 2008, Higashiyama 2011, and Hidese 2019 remain solid, independent of this specific bottle. What's in question is whether this specific product, at this dose, at this purity, at this price, is something a reader can actually confirm and buy — and as of Sep 8, 2026, it is neither confirmable nor purchasable. If you want a confirmed high dose or a checkable purity claim, NOW Foods (#1) and Sports Research (#2) both carry Suntheanine's patent-tier standardisation on listings we could verify. This one is a skip until a live, panel-legible listing exists to re-audit.
Trial-replication alternative — Suntheanine-patented L-Theanine at 200 mg per cap (the Owen 2008 dose). Higher per-mg cost but cleaner trial-fidelity argument. The right pick for first-time L-Theanine buyers + pure acute-focus protocols.
See it on the list →Athlete-tested alternative — Informed Sport certified Suntheanine for competing athletes who need batch-tested certification. ~2x Toniiq's per-mg cost. Right pick for NCAA/WADA-tested sport.
See it on the list →Different mechanism alternative — Alpha-GPC for the acetylcholine substrate + cognition/power output pathway. Stacks cleanly with Toniiq L-Theanine pre-training for the full focus + motor-unit protocol.
See it on the list →L-Theanine at 50-200 mg measurably increased alpha-wave EEG activity (the 'relaxed alertness' band) within 30-45 minutes of dosing. Established the acute mechanism behind the focus + relaxation effect that anchors the full L-Theanine evidence base.
L-Theanine at 200 mg measurably reduced stress response (heart rate + salivary cortisol) under cognitive load. Characterized the ceiling effect at 200-400 mg — additional dose past this range did not add additional stress-reduction signal. Anchors the upper-trial-range dose justification for 400 mg per cap formats.
L-Theanine 100 mg + caffeine 50 mg significantly improved accuracy on attention-switching and reaction-time tasks vs caffeine alone or placebo. The cornerstone trial behind the L-Theanine + caffeine acute focus stack at the 1:2 L-Theanine:caffeine ratio.
L-Theanine 200 mg for 4 weeks reduced stress-related symptoms, improved sleep quality (subjective sleep onset latency), and modestly improved cognitive function in healthy adults. Anchors the sleep-onset use case for L-Theanine at the upper-trial-range dose.
